EP0961793A4 - Polymers incorporating peptides - Google Patents

Polymers incorporating peptides

Info

Publication number
EP0961793A4
EP0961793A4 EP98901884A EP98901884A EP0961793A4 EP 0961793 A4 EP0961793 A4 EP 0961793A4 EP 98901884 A EP98901884 A EP 98901884A EP 98901884 A EP98901884 A EP 98901884A EP 0961793 A4 EP0961793 A4 EP 0961793A4
Authority
EP
European Patent Office
Prior art keywords
polymers incorporating
incorporating peptides
peptides
polymers
incorporating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98901884A
Other languages
German (de)
French (fr)
Other versions
EP0961793A1 (en
Inventor
David Charles Jackson
Neil Martin O'brien-Simpson
Lorena Elizabeth Brown
Wieguang Zeng
Nicholas Jon Ede
Evelyn Rosemary Brandt
Michael Francis Good
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Walter and Eliza Hall Institute of Medical Research
CSL Ltd
University of Melbourne
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Walter and Eliza Hall Institute of Medical Research
CSL Ltd
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5071A external-priority patent/AUPO507197A0/en
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Walter and Eliza Hall Institute of Medical Research, CSL Ltd, University of Melbourne filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of EP0961793A1 publication Critical patent/EP0961793A1/en
Publication of EP0961793A4 publication Critical patent/EP0961793A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
EP98901884A 1997-02-11 1998-02-10 Polymers incorporating peptides Withdrawn EP0961793A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPO5071A AUPO507197A0 (en) 1997-02-11 1997-02-11 Peptide polymers
AUPO507197 1997-02-11
CA2217321 1997-10-03
CA002217321A CA2217321A1 (en) 1997-02-11 1997-10-03 Polymers incorporating peptides
PCT/AU1998/000076 WO1998034968A1 (en) 1997-02-11 1998-02-10 Polymers incorporating peptides

Publications (2)

Publication Number Publication Date
EP0961793A1 EP0961793A1 (en) 1999-12-08
EP0961793A4 true EP0961793A4 (en) 2000-09-06

Family

ID=25645360

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98901884A Withdrawn EP0961793A4 (en) 1997-02-11 1998-02-10 Polymers incorporating peptides

Country Status (3)

Country Link
EP (1) EP0961793A4 (en)
JP (1) JP2001513120A (en)
WO (1) WO1998034968A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100955668B1 (en) 1999-02-05 2010-05-06 더 유니버시티 오브 멜버른 T helper cell epitopes
GB9930585D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
NZ526247A (en) * 2000-11-08 2005-02-25 Commw Scient Ind Res Org Methods for identifying antibacterial agents with selectivity for members of the eubacteria
FR2828648A1 (en) * 2001-08-16 2003-02-21 Adam Bouaziz CONSTITUTION OF AN EXTRACTIBLE VACCINE FROM AN IMMUNOGENIC INSERT.
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
WO2010003178A1 (en) * 2008-07-07 2010-01-14 The University Of Melbourne A synthetic vaccine component
ES2333511B1 (en) * 2009-06-15 2011-01-24 Universitat De Girona POLYMERIZABLE DERIVATIVES OF ANTIMICROBIAL LINEAR PEPTIDES.
KR102003904B1 (en) * 2016-08-17 2019-07-25 연세대학교 산학협력단 manufacturing method of peptide-polymer conjugate with stabilized α-helices, peptide-polymer conjugate thereby

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585024A1 (en) * 1985-07-19 1987-01-23 Centre Nat Rech Scient BRANCHED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR APPLICATIONS, AND CORRESPONDING MONOMERS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486275T2 (en) * 1983-11-10 1994-09-08 Genetic Systems Corp Polymerizable compounds containing integral antibodies and their applications in immunoassays with separation induced by polymerization.
DE69118826T2 (en) * 1990-11-27 1996-11-14 Fuji Photo Film Co Ltd Propenamide derivatives, their polymers, copolymers and their use
CZ279785B6 (en) * 1991-02-01 1995-06-14 Galena, A.S. Directed polymeric conjugates of cyclosporin
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
DE4228135A1 (en) * 1992-08-25 1994-03-03 Bayer Ag Polymerizable dipeptides, synthesis, polymerization and use of the polymers for chromatographic enantiomer separation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585024A1 (en) * 1985-07-19 1987-01-23 Centre Nat Rech Scient BRANCHED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR APPLICATIONS, AND CORRESPONDING MONOMERS

Also Published As

Publication number Publication date
WO1998034968A1 (en) 1998-08-13
EP0961793A1 (en) 1999-12-08
JP2001513120A (en) 2001-08-28

Similar Documents

Publication Publication Date Title
ZA988420B (en) Novel polymers
GB9800936D0 (en) Biofunctional polymers
HK1036997A1 (en) Peptides
GB9600272D0 (en) Polymers
AU5566698A (en) Polymers
GB9718110D0 (en) Peptides
EP0961793A4 (en) Polymers incorporating peptides
AU5871798A (en) Polymers
AU1999999A (en) Contryphan peptides
GB9700154D0 (en) Peptides
ZA9811471B (en) Polymer
GB9812675D0 (en) Peptides
EP0996457A4 (en) Fsh-releasing peptides
GB9716454D0 (en) Polymer
AUPO507197A0 (en) Peptide polymers
GB9807890D0 (en) Peptides
GB9613705D0 (en) Novel peptides
GB9700830D0 (en) Hexaphenylbenzene based polymers
GB9713146D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9701024D0 (en) Peptides
GB9701813D0 (en) Polymers
GB9727134D0 (en) Polymers
GB9712744D0 (en) Polymers
GB9718133D0 (en) Polymers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990830

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GOOD, MICHAEL, FRANCIS

Inventor name: BRANDT, EVELYN, ROSEMARY DEP OF MICRO & IMMUNO.

Inventor name: EDE, NICHOLAS, JON

Inventor name: ZENG, WIEGUANG

Inventor name: BROWN, LORENA, ELIZABETH

Inventor name: O'BRIEN-SIMPSON, NEIL, MARTIN

Inventor name: JACKSON, DAVID, CHARLES

A4 Supplementary search report drawn up and despatched

Effective date: 20000725

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040629